The US Food and Drug Administration (FDA) said on Friday it had granted emergency use authorization to Eli Lilly and Co's COVID-19 antibody drug for the treatment of patients with mild to moderate disease who are 12 years and older.
US FDA authorizes Lilly COVID-19 drug
By REUTERS
05/10/2024 03:29 PM
By REUTERS
05/10/2024 09:31 AM
By REUTERS
05/10/2024 12:49 AM
By REUTERS
05/09/2024 06:54 PM
By REUTERS
05/09/2024 05:05 PM
By ALON HACHMON
05/09/2024 04:56 PM